Back
Merck KGaA 10K Form
Sell
30
MKGAF
Merck KGaA
Last Price:
$128.10
Seasonality Move:
2.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MKGAF News And Ratings
See the #1 stock for the next 7 days that we like better than MKGAF
MKGAF Financial Statistics
Sales & Book Value
| Annual Sales: | $23.8B |
|---|---|
| Cash Flow: | $387.4M |
| Price / Cash Flow: | 130.38 |
| Annual Sales: | $77.23 |
| Price / Book: | 1.66 |
Profitability
| EPS (TTM): | 6.75740 |
|---|---|
| Net Income (TTM): | $2.9B |
| Gross Margin: | $13.4B |
| Return on Equity: | 8.96% |
| Return on Assets: | 5.19% |
Merck KGaA Earnings Forecast
Key Merck KGaA Financial Ratios
-
The Gross Profit Margin over the past 24 years for MKGAF is 56.35%.
-
The Selling, General & Administrative Expenses for MKGAF have been equal to 28.43% of Gross Profit Margin.
-
The Research & Development expenses have been 11.29% of Revenue.
-
The Interest Expense is 10.02% of Operating Income.
-
The Net Earning history of MKGAF is 12.39% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 12 years.
Merck KGaA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MKGAF |
| Website: | merckgroup.com |
Debt
| Debt-to-Equity Ratio: | 0.42 |
|---|---|
| Current Ratio: | 1.46 |
| Quick Ratio: | 0.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.92 |
|---|---|
| Forward P/E Ratio: | 0 |
MKGAF Technical Analysis vs Fundamental Analysis
Sell
30
Merck KGaA (MKGAF)
is a Sell
Is Merck KGaA a Buy or a Sell?
-
Merck KGaA stock is rated a SellThe current Merck KGaA [MKGAF] share price is $128.10. The Score for MKGAF is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.